Blood test could predict arthritis severity in kids

NCT ID NCT05534347

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is collecting blood and joint fluid samples from 300 children and young adults with juvenile idiopathic arthritis (JIA) to see if certain markers can predict how severe the disease will become. Researchers will track participants' symptoms, treatments, and joint damage over time. The goal is to find better ways to identify which patients need more aggressive treatment early on.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors predict which children with juvenile idiopathic arthritis will have more severe disease, allowing earlier and more personalized treatment.
What could go wrong: This is an observational study, not a treatment trial. It may not lead to immediate changes in care, and the markers studied might not prove to be reliable predictors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for JUVENILE IDIOPATHIC ARTHRITIS (JIA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cone-rod dystrophy 10 cornea plana 1, autosomal dominant juvenile idiopathic arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

JUVENILE IDIOPATHIC ARTHRITIS (JIA)

Contacts and locations

Locations

Rheumatology Department, Cochin Hospital
RECRUITING

Paris, IDF, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.